111 related articles for article (PubMed ID: 11905547)
1. Bronchodilating effect of oxitropium bromide in heart disease patients with exacerbations of COPD: double-blind, randomized, controlled study.
Centanni S; Santus P; Casanova F; Carlucci P; Boveri B; Castagna F; Di Marco F; Cazzola M
Respir Med; 2002 Mar; 96(3):137-41. PubMed ID: 11905547
[TBL] [Abstract][Full Text] [Related]
2. Effects of formoterol, salmeterol or oxitropium bromide on airway responses to salbutamol in COPD.
Cazzola M; Di Perna F; Noschese P; Vinciguerra A; Calderaro F; Girbino G; Matera MG
Eur Respir J; 1998 Jun; 11(6):1337-41. PubMed ID: 9657576
[TBL] [Abstract][Full Text] [Related]
3. A comparison of bronchodilating effects of salmeterol and oxitropium bromide in stable chronic obstructive pulmonary disease.
Cazzola M; Matera MG; Di Perna F; Calderaro F; Califano C; Vinciguerra A
Respir Med; 1998 Feb; 92(2):354-7. PubMed ID: 9616538
[TBL] [Abstract][Full Text] [Related]
4. Comparative dose-response study of three anticholinergic agents and fenoterol using a metered dose inhaler in patients with chronic obstructive pulmonary disease.
Ikeda A; Nishimura K; Koyama H; Izumi T
Thorax; 1995 Jan; 50(1):62-6. PubMed ID: 7886652
[TBL] [Abstract][Full Text] [Related]
5. Acute effect of pretreatment with single conventional dose of salmeterol on dose-response curve to oxitropium bromide in chronic obstructive pulmonary disease.
Cazzola M; Di Perna F; Centanni S; Califano C; Donner CF; D'Amato M; D'Amato G
Thorax; 1999 Dec; 54(12):1083-6. PubMed ID: 10567627
[TBL] [Abstract][Full Text] [Related]
6. Effects of replacing oxitropium with tiotropium on pulmonary function in patients with COPD: a randomized study.
Incorvaia C; Riario-Sforza GG; Pravettoni C; Dugnani N; Paterniti F; Pessina L; Fumagalli M
Respir Med; 2007 Mar; 101(3):476-80. PubMed ID: 16919926
[TBL] [Abstract][Full Text] [Related]
7. Anti-cholinergic bronchodilators versus beta2-sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary disease.
McCrory DC; Brown CD
Cochrane Database Syst Rev; 2002; 2003(4):CD003900. PubMed ID: 12519615
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy of tiotropium bromide (Spiriva) in patients with chronic-obstructive pulmonary disease (COPD) of different severities].
Beeh KM; Beier J; Buhl R; Stark-Lorenzen P; Gerken F; Metzdorf N;
Pneumologie; 2006 Jun; 60(6):341-6. PubMed ID: 16761228
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the efficacy and safety of tiotropium bromide (5 µg) inhaled via Respimat in Chinese patients with chronic obstructive pulmonary disease.
Tang Y; Massey D; Zhong NS
Chin Med J (Engl); 2013; 126(19):3603-7. PubMed ID: 24112149
[TBL] [Abstract][Full Text] [Related]
10. Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Dutch Study Group.
Maesen FP; Smeets JJ; Sledsens TJ; Wald FD; Cornelissen PJ
Eur Respir J; 1995 Sep; 8(9):1506-13. PubMed ID: 8575576
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the bronchodilating effects of oxitropium bromide and fenoterol in patients with chronic obstructive pulmonary disease.
Koyama H; Nishimura K; Ikeda A; Izumi T
Chest; 1993 Dec; 104(6):1743-7. PubMed ID: 8252955
[TBL] [Abstract][Full Text] [Related]
12. Effect of inhaled bronchodilators on inspiratory capacity and dyspnoea at rest in COPD.
Di Marco F; Milic-Emili J; Boveri B; Carlucci P; Santus P; Casanova F; Cazzola M; Centanni S
Eur Respir J; 2003 Jan; 21(1):86-94. PubMed ID: 12570114
[TBL] [Abstract][Full Text] [Related]
13. A 4-year trial of tiotropium in chronic obstructive pulmonary disease.
Tashkin DP; Celli B; Senn S; Burkhart D; Kesten S; Menjoge S; Decramer M;
N Engl J Med; 2008 Oct; 359(15):1543-54. PubMed ID: 18836213
[TBL] [Abstract][Full Text] [Related]
14. Pharmacodynamic steady state of tiotropium in patients with chronic obstructive pulmonary disease.
van Noord JA; Smeets JJ; Custers FL; Korducki L; Cornelissen PJ
Eur Respir J; 2002 Apr; 19(4):639-44. PubMed ID: 11998992
[TBL] [Abstract][Full Text] [Related]
15. Reproducibility of forced inspiratory and expiratory volumes after bronchodilation in patients with COPD or asthma.
Taube C; Kanniess F; Grönke L; Richter K; Mücke M; Paasch K; Eichler G; Jörres RA; Magnussen H
Respir Med; 2003 May; 97(5):568-77. PubMed ID: 12735677
[TBL] [Abstract][Full Text] [Related]
16. [Long-acting bronchodilator agents are the choice in COPD. Keeping the airways open continuously].
MMW Fortschr Med; 2007 Nov; 149(47):54. PubMed ID: 18064817
[No Abstract] [Full Text] [Related]
17. Oxitropium bromide. Dose-response and time-response study of a new anticholinergic bronchodilator drug.
Frith PA; Jenner B; Dangerfield R; Atkinson J; Drennan C
Chest; 1986 Feb; 89(2):249-53. PubMed ID: 3510822
[TBL] [Abstract][Full Text] [Related]
18. Bronchodilator reversibility, exercise performance and breathlessness in stable chronic obstructive pulmonary disease.
Hay JG; Stone P; Carter J; Church S; Eyre-Brook A; Pearson MG; Woodcock AA; Calverley PM
Eur Respir J; 1992 Jun; 5(6):659-64. PubMed ID: 1628722
[TBL] [Abstract][Full Text] [Related]
19. Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium.
Vincken W; van Noord JA; Greefhorst AP; Bantje TA; Kesten S; Korducki L; Cornelissen PJ;
Eur Respir J; 2002 Feb; 19(2):209-16. PubMed ID: 11871363
[TBL] [Abstract][Full Text] [Related]
20. Oxitropium bromide improves exercise performance in patients with COPD.
Ikeda A; Nishimura K; Koyama H; Sugiura N; Izumi T
Chest; 1994 Dec; 106(6):1740-5. PubMed ID: 7988193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]